InVivo Therapeutics Holdings Corp. Stock
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 USD | 0.00% | +2.78% | -49.32% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | 6 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1 week | +2.78% | ||
Current month | +68.18% | ||
1 month | +58.80% | ||
3 months | -43.08% | ||
6 months | -60.22% | ||
Current year | -49.32% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.37 | 0.00% | 4,338 |
24-04-30 | 0.37 | 0.00% | 851 |
24-04-29 | 0.37 | 0.00% | 787 |
24-04-26 | 0.37 | +2.78% | 1,122 |
24-04-25 | 0.36 | 0.00% | 15,757 |
Delayed Quote OTC Markets, May 01, 2024 at 02:17 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-49.32% | 1.15M | |
+8.33% | 217B | |
+6.72% | 183B | |
+10.18% | 131B | |
+24.91% | 106B | |
-0.95% | 62.16B | |
+10.56% | 51.02B | |
+4.81% | 50.89B | |
-0.24% | 40.16B | |
+1.22% | 34.79B |
- Stock Market
- Equities
- NVIV Stock